<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04651322</url>
  </required_header>
  <id_info>
    <org_study_id>1-2019-0023</org_study_id>
    <nct_id>NCT04651322</nct_id>
  </id_info>
  <brief_title>Quantified Analysis of Neuronal Recovery Using Myelin Imaging After Robot Assisted Upper Arm Training in Subacute Stroke Patients</brief_title>
  <official_title>Quantified Analysis of Neuronal Recovery Using Myelin Imaging After Robot Assisted Upper Arm Training in Subacute Stroke Patients: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Quantitative assessment method developed for brain plasticity through disability&#xD;
           rehabilitation using a brain imaging technique.&#xD;
&#xD;
        -  Development of brain imaging technology to improve understanding of brain plasticity&#xD;
           during rehabilitation and to improve the efficiency of rehabilitation treatment for&#xD;
           people with brain injury. ○ Development of the latest brain function image analysis&#xD;
           algorithm and data processing technology&#xD;
&#xD;
             -  Development of new technology for imaging brain plasticity in addition to existing&#xD;
                functional imaging technology and diffuse imaging technology (Example: Myelinated&#xD;
                brain imaging technology, susceptibility imaging (SWI) technology)&#xD;
&#xD;
             -  Development of image reconstruction software technology using new image technology&#xD;
&#xD;
             -  Multi-image and repeated shot data processing technology, wheat analysis technology&#xD;
                development (Example: 3D registration technology, automated segmentation&#xD;
                technology)&#xD;
&#xD;
        -  Conducted clinical research on clinical quantitative evaluation of brain plasticity due&#xD;
           to rehabilitation treatment&#xD;
&#xD;
             -  Recruitment of a group of patients for pursuing plasticity through rehabilitation&#xD;
                among stroke patients (estimating the number of sample patients by setting a&#xD;
                specific patient group and analyzing statistical power)&#xD;
&#xD;
             -  Image-based brain change analysis through patient rehabilitation and before and&#xD;
                after imaging&#xD;
&#xD;
             -  Comparative analysis through securing a control group and activating the control&#xD;
                group. Derivation of clinical relevance through comparison with rehabilitation&#xD;
                process&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl-Meyer Assessment (FMA)</measure>
    <time_frame>before training(0week)</time_frame>
    <description>The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fugl-Meyer Assessment (FMA)</measure>
    <time_frame>after training(4week)</time_frame>
    <description>The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Training group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>upper robot Robot assisted upper arm training(RAT)</intervention_name>
    <description>The training group received an additional upper robot Robot assisted upper arm training(RAT) with Armeopower® 5 times per week for 4weeks.&#xD;
*Robot Assisted Arm training + Conventional occupational therapy</description>
    <arm_group_label>Training group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Conventional therapy</intervention_name>
    <description>The control group received the usual conventional therapy *Only Conventional occupational therapy</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. less than 6 months after onset of the stroke&#xD;
&#xD;
          2. have FMA score greater than 7&#xD;
&#xD;
          3. have confirmed that the integrity of the Corticospinal Tract (CST) is preserved in&#xD;
             Diffusion Tensor Imaging (DTI) taken using&#xD;
&#xD;
          4. over 20 years of age&#xD;
&#xD;
          5. can understand and participated in study&#xD;
&#xD;
          6. consented to this study in writing or verbally&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. quadriplegia&#xD;
&#xD;
          2. past history of stroke&#xD;
&#xD;
          3. past history of Musculoskeletal disease or history of Neurological diseases&#xD;
&#xD;
          4. have a history of injury to the upper limb and upper chest, surgery, or peripheral&#xD;
             nerve damage&#xD;
&#xD;
          5. have skin ulcers or skin diseases such as open wounds that have difficulty applying&#xD;
             RAT&#xD;
&#xD;
          6. Pregnant woman&#xD;
&#xD;
          7. If it is judged that this clinical participation is not appropriate according to the&#xD;
             judgment of medical doctor&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deog Young Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Severance Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Deog Young Kim</last_name>
    <phone>+82-2-2228-3714</phone>
    <email>KIMDY@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yonsei Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deog Young Kim</last_name>
      <phone>+82-2-2228-3714</phone>
      <email>KIMDY@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 25, 2020</study_first_submitted>
  <study_first_submitted_qc>November 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>November 25, 2020</last_update_submitted>
  <last_update_submitted_qc>November 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

